Oral factor Xa inhibitors in acute coronary syndromes

被引：1

作者：

Tapp, Luke ^{[1
]}

Wrigley, Ben ^{[1
]}

Lip, Gregory Y. H. ^{[1
]}

机构：

[1] Univ Birmingham, Haemostasis Thrombosis & Vasc Biol Unit, Ctr Cardiovasc Sci, City Hosp, Birmingham B18 7QH, W Midlands, England

来源：

NATURE REVIEWS CARDIOLOGY | 2009年 / 6卷 / 10期

关键词：

DEEP-VEIN THROMBOSIS; RIVAROXABAN; TRIAL; CLOPIDOGREL; APIXABAN; ASPIRIN; SAFETY;

D O I：

10.1038/nrcardio.2009.160

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Factor Xa inhibitors, a new class of oral anticoagulants, have been evaluated in the phase II ATLAS ACS-TIMI 46 and APPRAISE trials. addition of these agents to standard therapy has tended to reduce the incidence of adverse cardiovascular events at the expense of a dose-dependent increase in the risk of bleeding complications.

引用

页码：619 / 620

页数：3

共 50 条

[21] Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of deep vein thrombosis
Robertson, Lindsay
Kesteven, Patrick
McCaslin, James E.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (06):
[22] Direct thrombin inhibitors in acute coronary syndromes
Jang, IK
LANCET, 2002, 360 (9331): : 491 - 492
[23] Direct oral factor Xa inhibitors in patients with morbid obesity
Kushnir, Margarita
LANCET HAEMATOLOGY, 2019, 6 (09): : E447 - E447
[24] Oral factor Xa inhibitors for the prevention of stroke in atrial fibrillation
Piccini, Jonathan P.
Lopes, Renato D.
Mahaffey, Kenneth W.
CURRENT OPINION IN CARDIOLOGY, 2010, 25 (04) : 312 - 320
[25] Throwing it in reverse: An update on reversal of oral factor Xa inhibitors
Gilbert, Brian W.
Reeder, Jacob A.
Alkhalifah, Mohammed A.
Moran, David A.
Corvino, Michael A.
AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2019, 37 (10): : 1978 - 1980
[26] A new factor Xa inhibitor for acute coronary syndrome
Sharmini Rajanayagam
Nature Reviews Cardiology, 2009, 6 (12) : 731 - 731
[27] Oral Factor Xa and Direct Thrombin Inhibitors: A Clinical Perspective
Thethi, Indermohan
Lewis, Bruce
Fareed, Jawed
JOURNAL OF BURN CARE & RESEARCH, 2012, 33 (04): : 453 - 461
[28] Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors
Kaatz, Scott
Kouides, Peter A.
Garcia, David A.
Spyropolous, Alex C.
Crowther, Mark
Douketis, Jim D.
Chan, Anthony K. C.
James, Andra
Moll, Stephan
Ortel, Thomas L.
Van Cott, Elizabeth M.
Ansell, Jack
AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 : S141 - S145
[29] Oral anticoagulation with factor Xa and thrombin inhibitors: on the threshold of change
Zikria, Jennifer Carreiro
Ansell, Jack
CURRENT OPINION IN HEMATOLOGY, 2009, 16 (05) : 347 - 356
[30] Novel Oral Factor Xa and Thrombin Inhibitors in the Management of Thromboembolism
Eriksson, Bengt I.
Quinlan, Daniel J.
Eikelboom, John W.
ANNUAL REVIEW OF MEDICINE, VOL 62, 2011, 2011, 62 : 41 - 57

← 1 2 3 4 5 →